Adderall XR Safety During Pregnancy

Safety Profile of Adderall XR in Pregnancy

The American College of Obstetricians and Gynecologists suggests that amphetamines do not appear to be associated with major congenital malformations, including cardiac malformations, or other significant adverse obstetrical or developmental outcomes 1, 2, 3
There is a possible small increased risk for gastroschisis, with an adjusted odds ratio of 3.0 and a 95% confidence interval of 1.2-7.4, though the absolute risk remains very small given the rarity of gastroschisis, which has a population prevalence of 0.05% 1
Possible small increased risk for preeclampsia, with an adjusted relative risk of 1.29 and a 95% confidence interval of 1.11-1.49, though this association has not been consistently found across studies 1, 3
Potential small increased risk for preterm birth when stimulant use continues in the second half of pregnancy, with an adjusted relative risk of 1.30 and a 95% confidence interval of 1.10-1.55 1

Discontinuing psychostimulant treatment during pregnancy can lead to worse maternal mental health outcomes and significant impairments in functioning, according to the American College of Obstetricians and Gynecologists 1, 2
Untreated ADHD has been associated with increased risks for spontaneous abortion and preterm birth, as reported by the American College of Obstetricians and Gynecologists 1, 2

Regular monitoring of blood pressure and pulse is essential, as stimulants can increase these parameters, and the American College of Obstetricians and Gynecologists recommends monitoring for potential increased risks of preeclampsia and preterm birth 1, 3, 5
If Adderall XR is continued during pregnancy, the maximum recommended dose remains 50 mg daily, though this guideline is from Praxis Medical Insights, and the American College of Obstetricians and Gynecologists may have different recommendations 4, 5

Amphetamines are excreted in human milk, but therapeutic use during breastfeeding does not appear to adversely affect infants, according to the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists 1
The Hale lactation risk category for amphetamine mixed salts is L3, indicating moderately safe use during breastfeeding, as classified by the American Academy of Pediatrics 1

If medication risks are deemed too high, non-pharmacological approaches such as Dialectical Behavior Therapy (DBT) can be considered, as recommended by the American College of Obstetricians and Gynecologists and the American Psychiatric Association 1, 2
DBT has been modified for adults with ADHD and includes modules addressing poor concentration, disorganization, interpersonal relationships, and emotion regulation, according to the American Psychiatric Association 1, 2
Non-stimulant medications like bupropion may be considered as alternatives with potentially lower risk profiles, as suggested by the American College of Obstetricians and Gynecologists and the American Psychiatric Association 1, 2